DAN plays important compensatory roles in systemic-to-pulmonary shunt associated pulmonary arterial hypertension.

Compensatory decrease of DAN in hypertensive lungs may retard the deterioration of shunt-associated PAH, at least in part, by antagonizing BMP signalling pathway. Furthermore, DAN might be a potential biomarker for PAH/CHD.